TOXICITY OF 6-HYDROXYDOPAMINE AND DOPAMINE FOR DOPAMINERGIC-NEURONS IN CULTURE

被引:315
作者
MICHEL, PP
HEFTI, F
机构
[1] UNIV SO CALIF, ETHEL PERCY ANDRUS GERONTOL CTR, UNIV PK, MC-0191, LOS ANGELES, CA 90089 USA
[2] UNIV MIAMI, DEPT NEUROL, MIAMI, FL 33152 USA
关键词
cell cultures; MPTP; neurotoxicity; Parkinson's disease; substantia nigra;
D O I
10.1002/jnr.490260405
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Toxicity of 6‐hydroxydopamine (6‐OHDA) and dopamine were studied in cultures of dissociated fetal rat mesencephalic cells. To assess survival and function of dopaminergic cells we quantified the number of tyrosine hydroxylase‐positive cells and measured dopamine uptake. Non‐dopaminergic cells were monitored by counting the number of cells visible with phase‐contrast microscopy and measuring GABA uptake. 6‐OHDA, in contrast to MPP +, which selectively destroyed dopaminergic neurons, was found to be a non‐selective neurotoxin in this culture system. Between 10 and 100 μM, dopaminergic and non‐dopaminergic cells were destroyed. At concentrations frequently used to lesion catecholaminergic neurons in vivo, 6‐OHDA resulted in structural fixation and loss of viability of dopaminergic and non‐dopaminergic cells. Dopamine produced the same actions at slightly higher concentrations. One hundred to 300 μM was toxic for all cell types, and concentrations above 300 μM resulted in fixation. The findings suggest that 6‐OHDA cannot be considered a selective toxin for catecholaminergic neurons in vitro. The demonstrated toxicity of dopamine tends to support speculations that processes related to dopamine metabolism may play a role in the pathogenesis of Parkinson's disease. Copyright © 1990 Wiley‐Liss, Inc.
引用
收藏
页码:428 / 435
页数:8
相关论文
共 41 条
  • [1] [Anonymous], 1985, RAT NERVOUS SYSTEM
  • [2] BEAUDET A, 1984, MONOAMINE INNERVATIO, P109
  • [3] BREESE GR, 1970, J PHARMACOL EXP THER, V174, P413
  • [4] DEVELOPMENTAL CHARACTERISTICS OF BRAIN CATECHOLAMINES AND TYROSINE-HYDROXYLASE IN RAT - EFFECTS OF 6-HYDROXYDOPAMINE
    BREESE, GR
    TRAYLOR, TD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (02) : 210 - &
  • [5] METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE
    CHIBA, K
    TREVOR, A
    CASTAGNOLI, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) : 574 - 578
  • [6] Cohen G, 1983, J Neural Transm Suppl, V19, P89
  • [7] COHEN G, 1974, J BIOL CHEM, V249, P2447
  • [8] COYLE JT, 1969, J PHARMACOL EXP THER, V170, P221
  • [9] INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE
    DEXTER, DT
    WELLS, FR
    LEES, AJ
    AGID, F
    AGID, Y
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) : 1830 - 1836
  • [10] STUDIES ON THE FORMATION OF 6-HYDROXYDOPAMINE IN MOUSE-BRAIN AFTER ADMINISTRATION OF 2,4,5-TRIHYDROXYPHENYLALANINE (6-HYDROXYDOPA)
    EVANS, JM
    COHEN, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (05) : 1461 - 1467